Navigation Links
SpectraScience Receives Final European Certification
Date:10/10/2007

SAN DIEGO, Oct. 10 /PRNewswire-FirstCall/ -- SpectraScience, Inc. (OTC Bulletin Board: SCIE) announced today that it has received the final EC Marking Certification of the Company's quality system from the Notified Body G-MED. SpectraScience has been issued a certificate with reference to Annex II.3 of the European directive 93/42/EEC. In addition, ISO 9001:2000 and ISO 13485:2003 have been issued.

Jim Hitchin the Company's CEO said, "This certification is an important validation of our manufacturing quality controls and procedures. In addition, we are now qualified to sell our products throughout the European Union, as well as many other countries around the world."

SpectraScience has developed a multi-patented and proprietary WavSTAT(TM) Optical Biopsy System that is used by physicians to diagnose tissue to determine if it is normal, pre-cancerous, or cancerous within seconds. The WavSTAT(TM) System is currently approved by the FDA for use in detecting pre-cancer and cancer in the colon. A new application for detecting pre-cancers in the throat, sometimes called Barrett's esophagus, is being tested in a clinical trial. Cancer of the esophagus is more than 90% fatal and may develop as a result of chronic heartburn or GERD. Esophageal cancer is growing five times faster than all other cancers.

This news release contains forward looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements involve risks and uncertainties that may cause SpectraScience's actual results to differ materially from the results discussed in the forward-looking statements. Readers are urged to carefully review and consider the various disclosures made by SpectraScience in this news release, the Form 10-KSB and in SpectraScience's other reports filed with the Securities and Exchange Commission ("SEC") that attempt to advise interested
'/>"/>

SOURCE SpectraScience, Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. Infant receives first bloodless liver transplant
2. British MPs Say Prostate Cancer Receives Low Priority in the NHS
3. Fifth US Patient Receives Artificial Heart
4. Northfield Labs Receives FDA Comments
5. Abbott Receives CE Mark Certification
6. Zactima Receives Fast Track Designation By The FDA
7. East London Receives World Class New Private Hospital Facility
8. Brinda Karat Receives Legal Notice over Ramdev Issue
9. Quake-Hit Pakistan Receives 30 Field Hospitals From Cuba
10. Medtronic’s Insulin Pump Receives Regulatory Approva
11. Aurobindo Receives Approval from USFDA for anti-AIDS drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...ICAGO, Dec. 3 Research ...evice and functional MRI (fMRI) have found that,c...ding to a study presented,today at the annual mee...,(RSNA). This is the first study using fMRI to map...n. , "We have shown that the brain has the ...
(Date:12/2/2008)...UISVILLE, Ky., Dec. 2 A...d meaningful images from the bits of information w... Grawemeyer Award for Psychology. , Anne Treism...y Professor,of psychology at Princeton Universit...ogy prize from among 28 nominations. , Trei...
(Date:12/2/2008)...A team of researchers from Monash University, The ...ical School and Vanda Pharmaceuticals has found a ...nd sleep disorders caused by shift work. , Dr S...of Psychology, Psychiatry and Psychological Medici...n receptors in the brain, could be a highly effect...
(Date:12/2/2008)...tients given Trasylol have a higher death risk, da...lthDay News) -- A new study casts more doubt on t...o limit bleeding in patients undergoing surgery. ,... in the United States, where it was removed from t... and Australian researchers reviewed findings from...
Breaking Medicine News(10 mins):Health News:Robotic Technology Improves Stroke Rehabilitation 2Health News:Robotic Technology Improves Stroke Rehabilitation 3Health News:Theory of How Brain Builds Images Earns Grawemeyer Prize 2Health News:New medication brings hope of jet lag cure 2Health News:Another Study Warns of Risk From Cardiac Surgery Drug 2
... have said in the British Medical Journal that the...tals since 1990, based on mythical safety risks, a...phones were banned in hospitals after fears of the...and to prevent the potential confusion between the...
...ar 500,000 Americans develop pneumococcal pneumoni... serious, possibly fatal, illness. The October iss...g the word: A vaccine is available that helps prot...pneumonia and reduces the serious complications of...
... with allergic symptoms like wheezing, asthma, ha...nsitization to their infants too, according to a s...ts that the current practice of avoiding skin test... 4 or 5 should be reconsidered, so children in thi...
... a clear indication in a scientific journal regard...ing clinical trial//, the drug was tested on human...re drug reaction. But for the timely emergency car...ve been history. A Dutch report documenting the ...
Other Medicine News:Health News:Allergy Sufferers Pass on Allergies to their Children 2
(Date:12/1/2008)...wire-USNewswire/ -- A study has found that positro...imaging the breast, is not affected by either brea...rs that limit the effectiveness of standard mammog... presented today at the annual meeting of the Radi..., "The ability of PEM to detect cancer does not ...
(Date:12/1/2008)...ith ENB-0040 at Children,s Hospital, Health Scienc... Enobia Pharma, an emerging Canadia...apeutics for serious bone disorders, today announc...rogram for hypophosphatasia was dosed. Enobia is i... ENB-0040 for the treatment of this rare and often...
(Date:12/1/2008)... December 9 at 11:00 am ET to Discuss Phase 2 Stud...O, Calif., Dec. 1 Sune...pharmaceutical company focused on the development ..., today announced new data from its studies of vor...sented during the 50th American Society of Hematol...
(Date:11/28/2008)...swire/ -- German biotech company,Partec is expand...oring and,AIDS patient follow-up diagnostics for ...08, 2.5 million patient tests have been performed ...CyFlow" system, supporting already,more than 1 mi...tion of the,Partec innovation, the average cost o...
Breaking Medicine Technology:New Mammography Technology Effective in Detecting Breast Cancer 2New Mammography Technology Effective in Detecting Breast Cancer 3New Mammography Technology Effective in Detecting Breast Cancer 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3German Innovation for HIV/AIDS Diagnostics has Been Used 2.5 Million Times in 2008 2Medifast Adds New Crunchy Bars to Product Line 28861 1Medifast Adds New Crunchy Bars to Product Line 28861 2NCPA Statement on November 4th Election Results 28860 1NCPA Statement on November 4th Election Results 28860 2ConjuChem Provides Development Update 8911 1ConjuChem Provides Development Update 8911 2ConjuChem Provides Development Update 8911 3State fund advances titanium powder research 9 other Iowa State projects 5736 1State fund advances titanium powder research 9 other Iowa State projects 5736 2State fund advances titanium powder research 9 other Iowa State projects 5736 3State fund advances titanium powder research 9 other Iowa State projects 5736 4
BD Vacutainer® PST™ Tubes contain spray-coated lithium heparin and a gel for plasma separation. They are used for plasma determinations in chemistry.
MONOJECT Red/Yellow Mottled Stopper
BD Vacutainer® Specialty Tubes - Thrombin
BD Vacutainer® PST™ Tubes contain spray-coated lithium heparin and a gel for plasma separation. They are used for plasma determinations in chemistry.
Medicine Products: